204 related articles for article (PubMed ID: 11284261)
1. [Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome].
Di Rienzo L; Artuso A; Cerqua N
Acta Otorhinolaryngol Ital; 2000 Oct; 20(5):336-42. PubMed ID: 11284261
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of ASS-Associated Polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist - a prospective drug study on its antiinflammatory effects].
Grundmann T; Töpfner M
Laryngorhinootologie; 2001 Oct; 80(10):576-82. PubMed ID: 11602930
[TBL] [Abstract][Full Text] [Related]
3. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
[TBL] [Abstract][Full Text] [Related]
5. Effect of montelukast on quality of life in subjects with nasal polyposis accompanying bronchial asthma.
Yazıcı ZM; Sayın I; Bozkurt E; Kayhan FT
Kulak Burun Bogaz Ihtis Derg; 2011; 21(4):210-4. PubMed ID: 21762051
[TBL] [Abstract][Full Text] [Related]
6. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps.
Vuralkan E; Saka C; Akin I; Hucumenoglu S; Unal BU; Kuran G; Ocal B
Ther Adv Respir Dis; 2012 Feb; 6(1):5-10. PubMed ID: 22042749
[TBL] [Abstract][Full Text] [Related]
7. Role of leukotriene inhibitors in the postoperative management of nasal polyps.
Mostafa BE; Abdel Hay H; Mohammed HE; Yamani M
ORL J Otorhinolaryngol Relat Spec; 2005; 67(3):148-53. PubMed ID: 15925911
[TBL] [Abstract][Full Text] [Related]
8. [Nasal polyps is not a homogenous pathology].
Arcimowicz M; Balcerzak J; Samoliński BK
Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of nasal polyps after surgical treatment.
Jäntti-Alanko S; Holopainen E; Malmberg H
Rhinol Suppl; 1989; 8():59-64. PubMed ID: 2772495
[TBL] [Abstract][Full Text] [Related]
10. [Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease].
Almeida Arvizu V; Guidos Fogelbach G; Sánchez Sánchez B; Vásquez Nava F; Matta Campos J; López Medina L; Rivera Pérez J; Mejía Covarrubias F; Montero Mora P
Rev Alerg Mex; 2005; 52(4):151-8. PubMed ID: 16268183
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
12. Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma.
Jankowski R; Moneret-Vautrin DA; Goetz R; Wayoff M
Rhinology; 1992 Dec; 30(4):249-58. PubMed ID: 1470826
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
14. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
15. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
Saengpanich S; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
[TBL] [Abstract][Full Text] [Related]
17. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics.
Stevenson DD; Simon RA; Mathison DA; Christiansen SC
Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):477-82. PubMed ID: 11152169
[TBL] [Abstract][Full Text] [Related]
18. Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis.
Stewart RA; Ram B; Hamilton G; Weiner J; Kane KJ
Otolaryngol Head Neck Surg; 2008 Nov; 139(5):682-7. PubMed ID: 18984264
[TBL] [Abstract][Full Text] [Related]
19. Improvement in vulvar vestibulitis with montelukast.
Kamdar N; Fisher L; MacNeill C
J Reprod Med; 2007 Oct; 52(10):912-6. PubMed ID: 17977165
[TBL] [Abstract][Full Text] [Related]
20. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
Mucha SM; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]